Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Abbott introduces Panbio COVID antigen self-test in India

Ruchika Sharma13 July 2021 9:15 AM IST

In India, Abbott will offer self-tests for use at home, assisted professional testing at point of care and laboratories, as well as workplace testing...

WHO finds heart inflammation link to Pfizer, Moderna COVID vaccine shots

Ruchika Sharma12 July 2021 1:27 PM IST

"These cases occurred more often in younger men and after the second dose of the vaccine, typically within a few days after vaccination," the WHO said...

ENTOD Pharma plans to expand in medical cosmetics, ophthalmic surgical segments

Ruchika Sharma12 July 2021 9:15 AM IST

Mumbai: ENTOD Pharmaceuticals, an Indian international research-based pharmaceutical company with over four decades of pharmaceutical expertise in...

WHO to decide on emergency use listing of Bharat Biotech Covaxin in 4-6 weeks

Ruchika Sharma12 July 2021 9:00 AM IST

New Delhi: The World Health Organization (WHO) is likely to take a decision on including Bharat Biotech's COVID-19 vaccine Covaxin in the emergency...

Unichem Labs diabetes drug Sitagliptin gets USFDA approval

Ruchika Sharma11 July 2021 12:00 PM IST

Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Cipla arm's oral liquid dosage, nasal product unit acquired by Rubicon Research

Ruchika Sharma11 July 2021 11:00 AM IST

New Delhi: Specialty pharma firm Rubicon Research on Friday said it has acquired Meditab Specialities'' oral liquid dosage and nasal product...

Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillation

Bayer Finerenone gets USFDA approval to treat CKD associated with type 2 diabetes

Ruchika Sharma11 July 2021 10:00 AM IST

Berlin: Bayer has announced that the U.S. Food and Drug Administration (FDA) has approved finerenone, the first non-steroidal, selective...

Venus Remedies offers Covid-19 protection policy

Ruchika Sharma11 July 2021 9:00 AM IST

Chandigarh: Pharma company Venus Remedies on Saturday announced a Covid protection policy for its employees and their immediate family members.Under...

UP pharma firm slapped Rs 10 crore fine for violating safety norms

Ruchika Sharma10 July 2021 12:22 PM IST

There is also violation of safety norms and mere denial is not enough, the NGT said adding that the unit has to be held liable to pay compensation for...

Glenmark to conduct phase 3 trials of nasal spray it claims to be effective in COVID treatment

Ruchika Sharma10 July 2021 12:15 PM IST

New Delhi: Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray, which it claims to be effective in the treatment of...

Shilpa Medicare Partners NXI Therapeutics for Autoimmune Therapy Development, Manufacturing

MSN Labs, DRDE ink pact for COVID drug 2-DG

Ruchika Sharma10 July 2021 11:00 AM IST

New Delhi: Drug firm MSN Laboratories on Friday said it has entered into a licence agreement with the Defence Research & Development Establishment...

Working with Moderna to make its Covid-19 vaccine available in India, says Govt

Ruchika Sharma10 July 2021 10:00 AM IST

New Delhi: The government said on Friday that it is working actively with COVID-19 vaccine manufacturer Moderna to see how its vaccine can be imported...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok